SYNAPDX CORP has a total of 15 patent applications. Its first patent ever was published in 2012. It filed its patents most often in United States, WIPO (World Intellectual Property Organization) and Canada. Its main competitors in its focus markets computer technology, measurement and biotechnology are IMG INST FUER MEDIZINISCHE GENOMFORSCHUNG PLANUNGSGESELLSCHAFT M B H, ZHENGZHOU ZHONGDAO BIOTECHNOLOGY CO LTD and PUSCAS IOAN.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 8 | |
#2 | WIPO (World Intellectual Property Organization) | 4 | |
#3 | Canada | 2 | |
#4 | China | 1 |
# | Industry | |
---|---|---|
#1 | Computer technology | |
#2 | Measurement | |
#3 | Biotechnology | |
#4 | Electrical machinery and energy |
# | Technology | |
---|---|---|
#1 | Measuring microorganism processes | |
#2 | Analysing materials | |
#3 | Bioinformatics | |
#4 | Electric digital data processing | |
#5 | Healthcare informatics | |
#6 | Electric discharge tubes |
# | Name | Total Patents |
---|---|---|
#1 | Letovsky Stanley | 8 |
#2 | Geigenmuller Ute | 7 |
#3 | Pacula Maciej | 7 |
#4 | Damian Doris | 7 |
#5 | Depristo Mark A | 7 |
#6 | Lapidus Stanley N | 5 |
#7 | Tribble Theresa | 4 |
#8 | Luber Jeffrey R | 1 |
#9 | Lapidus Stanley | 1 |
#10 | Lapidus Stanly N | 1 |
Publication | Filing date | Title |
---|---|---|
US2015293072A1 | Methods and systems for determining autism spectrum disorder risk | |
US2015294081A1 | Methods and systems for determining autism spectrum disorder risk | |
WO2013166217A2 | Systems and methods for normalizing gene expression profiles of biological samples having a mixed cell population | |
US2014045702A1 | Systems and methods for distinguishing between autism spectrum disorders (asd) and non-asd development delay | |
WO2013103945A1 | Composite assay for developmental disorders | |
US2013035252A1 | Methods for determining a gene expression profile and for disease diagnosis |